By: Erik Swain, Katie Kalvaitis
MUNICH — In patients with transthyretin amyloidosis with cardiomyopathy, once-monthly eplontersen, in addition to current standard treatments, did
Katie Kalvaitis is a Senior Editorial Director at Healio. With a focus on cardiology, endocrinology, and women’s health, she has extensive experience in medical publishing and has covered a wide range of topics including pulmonology, infectious diseases, and pediatrics. Kalvaitis's work has been recognized by the American Society of Healthcare Publication Editors and the North American Menopause Society Media Award for her contributions to expanding knowledge in healthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Katie Kalvaitis predominantly covers medical research, diabetes treatment, cardiac health, pregnancy complications, and women's health. Her articles often cite data and press releases.
To effectively reach out to Katie for potential coverage or expert commentary, consider offering access to exclusive data or insights related to ongoing studies in the areas she covers. Additionally, experts with a deep understanding of medical research outcomes or groundbreaking developments in diabetes treatment and cardiac health are likely to capture her interest.
It appears that Katie does not have a specific geographic focus but rather concentrates on providing comprehensive coverage of healthcare-related topics from various locations.
This information evolves through artificial intelligence and human feedback. Improve this profile .